The purpose of the Plan is to encourage and enable the officers, employees, Non-Employee Directors and consultants of Alkermes plc, an Irish public limited company (the 'Company'), and its Subsidiaries upon whose judgment, initiative and efforts the Company and its Subsidiaries largely depend for the . The campaign is intended to help raise awareness about alcohol dependence and encourage people who are rethinking their relationship . Manufacturing and royalty revenues. View All with Free Trial. Alkermes's advertising profile, including ad spend, recent creative, company contacts, & the analysis you need to reach key decision makers and generate more business. The MarketWatch News Department was not involved in the creation of this content. DUBLIN, April 19, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it commenced binding arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica . 526,675 ET. When a company such as Alkermes splits its shares, the market capitalization before and after . To exercise the access, data portability, and deletion rights described above, please submit a verifiable consumer request to us by emailing us at dataprotection@alkermes.com. The principal . This was a 2 for 1 split, meaning for each share of ALKS owned pre-split, the shareholder now owned 2 shares. Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. Revenues: Product sales, net $ 524,499 $ 450,334 . The decline came after the company announced on Monday that it had received notices of partial termination from . There are 18 companies in the Alkermes, Inc. corporate family. ALKERMES PHARMA IRELAND LIMITED has 465 employees at this location and generates $685.00 million in sales (USD). DUBLIN, Sept. 22, 2021 /PRNewswire/ -- A new online survey conducted during the COVID-19 pandemic by The Harris Poll on behalf of Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), found that 17% of respondents aged 21 and over reported drinking patterns that met the survey criteria for "heavy drinking"*. The company's total debt outstanding as of March 31, 2022 was $295.2 million. CONTENT: Press Release. Company Description: ALKERMES PHARMA IRELAND LIMITED is located in ATHLONE, Ireland and is part of the Pharmaceutical and Medicine Manufacturing Industry. Balance Sheet. 3 Branches. Alkermes plc announced that it received notices of partial termination in respect of two license agreements with Janssen Pharmaceutica N.V., a subsidiary of Johnson & Johnson and, under these agreements, a licensee and recipient of Alkermes' nanoparticulate formulation technology, known as NanoCrystal® technology. The report contains detailed information about Alkermes, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history. Alkermes is a specialty biopharmaceutical company that develops long-acting medications for the treatment of the central nervous system. Print. Alkermes ( ALKS -1.94%) Q1 2022 Earnings Call. . Overview. Their forecasts range from $25.00 to $36.00. Selected Financial Information (Unaudited) Condensed Consolidated Statements of Operations - GAAP. other than the Company or any of its Subsidiaries, or a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its Subsidiaries, is or becomes the "beneficial owner" (as defined in Rule 13d-3 under said Act), . Shares of Alkermes ( ALKS 4.16% ) were sinking 14.3% as of 11 a.m. EST on Tuesday. Manufacturing and royalty revenues . An itemized reconciliation between projected loss per share on a GAAP basis and projected earnings per share on a non-GAAP basis is as follows: (In millions, except per share data) Amount. Year Ended . Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. Alkermes has 2,245 employees across 5 locations and $1.17 B in annual revenue in FY 2021. Alkermes plc (Nasdaq: ALKS) is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases and immuno-oncology. DUBLIN , Sept. 22, 2021 /CSRwire/ -- A new online survey conducted during the COVID-19 pandemic by The Harris Poll on behalf of Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), found that 17% of respondents aged 21 and over reported drinking patterns that met . Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), recently announced former professional baseball player and World Series champion, CC Sabathia, as a spokesperson for the company's My Relationship with Alcohol campaign, which is designed to help raise awareness about the disease of alcohol dependence and encourage people who are rethinking their relationship with alcohol to reach . Get a D&B Hoovers Free Trial. By Britain Eakin. ), a Pennsylvania corporation organized in 1987, is a biotechnology company that develops products based on sophisticated drug delivery technologies to enhance therapeutic outcomes in major diseases. Only you, or someone legally authorized to act on your behalf, may make a verifiable consumer request related to your personal information. Apr 27, 2022, 8:00 a.m. Last ran on Boston Business Journal . . "Our strong first quarter results reflect continued momentum across the business, and a sharp operational focus that provides a solid foundation to drive further growth of our proprietary products and advance our . On average, they anticipate Alkermes' share price to reach $30.67 in the next year. December 31, 2018 . Revenues for the 12 months ended September 30, 2021 totaled approximately $1.1 billion. ET MALVERN, Pa., May 04, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the "Company"), a pharmaceutical company focused on . March 31, 2021. Itemized Lobbying Expenses for Alkermes Inc. The conference call may be accessed by dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 . . Under these agreements, Janssen received access and rights to Alkermes' small particle pharmaceutical compound technology, known as . Company Description: Alkermes, Inc. is located in Waltham, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. 447,882 . ALKERMES PLC This Deed of . Alkermes plc and Subsidiaries. . The webcast may be accessed on the Investors section of Alkermes' website at www.alkermes.com. WHEREAS, the Company and Alkermes plc, a public limited company incorporated in Ireland (the "Parent"), desire to attract and retain the services of highly qualified individuals, such as Indemnitee, to serve the Parent, any of its subsidiaries (together, the "Alkermes Group" and individually, an "Alkermes Company" or, if more than . . View analysts' price targets for Alkermes or view top-rated stocks among Wall Street analysts. Alkermes, Inc., a subsidiary of Alkermes plc, announced former professional baseball player and World Series champion, CC Sabathia, as a spokesperson for the company's new My Relationship with Alcohol campaign. The company was founded in 2011 and is based in Waltham, Massachusetts. Alkermes plc and Subsidiaries. Table of Contents . The webcast may be accessed on the Investors section of Alkermes' website at www.alkermes . ; Under these agreements, Janssen received access and rights to Alkermes' small particle pharmaceutical compound technology, known as NanoCrystal Technology, enabling several products. ANJESO® Net Product Revenue Up 113% Compared to Same Period in Prior Year; Sixth Consecutive Quarter of Demand Growth First Cohort Dosed in Pediatric ANJESO Surgical Study Management to Host Investor Conference Call and Webcast Tomorrow at 8:30 a.m. New Survey Provides Insights Into Drinking Behaviors During the Pandemic. . 105,170 Year Ended . General Alkermes, Inc. (together with its subsidiaries, referred to as ?we?, ?us?, ?our? - At March 31, 2022, the company recorded cash, cash equivalents and total investments of $758.7 million, compared to $765.7 million at Dec. 31, 2021. Alkermes plc and Subsidiaries . View All with Free Trial . Selected Financial Information (Unaudited) Condensed Consolidated Statements of Operations - GAAP . On average, they anticipate Alkermes' share price to reach $30.67 in the next year. This suggests a possible upside of 6.2% from the stock's current price. or the ?Registrant? 14 Subsidiaries. The company's total debt . The split for ALKS took place on May 15, 2000. Janssen subsidiary related to license agreements for Alkermes' NanoCrystal technology. Alkermes plc is a biopharmaceutical company that focuses on central nervous system (CNS) diseases such as such as schizophrenia, depression, addiction and multiple sclerosis. Alkermes employees work in the laboratory, in the clinic and in the community, seeking to make a positive impact on the lives of people living with complicated and difficult-to-treat diseases. 3 Branches. Alkermes Inc. operates as a subsidiary of Alkermes plc. Alkermes is a specialty biopharmaceutical company that develops long-acting medications for the treatment of the central nervous system. NTC shall cause each of its Affiliates (other than NTC Subsidiaries) who dispose of DRAM Product in a manner that causes Micron IP Royalties to be due to provide a written report, which is certified by each such Affiliate's chief financial officer as complete and correct, setting forth in reasonable detail such Affiliate's dispositions of DRAM Product and corresponding Micron IP Royalties . Alternatively, please see the Rating Methodologies page on www.moodys.com for a copy of this methodology.Alkermes, Inc. is a US subsidiary of Dublin, Ireland-based Alkermes plc (collectively . WHEREAS, in light of the limited ability under Irish law for the Parent Company to exculpate or commit in advance to indemnify or advance expenses to its directors and secretary or the directors and secretaries of its subsidiaries, it is reasonable, prudent and desirable for the Company, acting in its own best interests as a member of the Alkermes Group, contractually to obligate itself to . Three Months Ended . Manufacturing and royalty revenues . Manage corporate subsidiaries, including filing of annual franchise tax reports and foreign business registrations, procurement of certificates of . Three Months Ended (In thousands, except per share data) March 31, 2022. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to . Under these agreements, Janssen received access and rights to Alkermes' small particle . Alkermes Controlled Therapeutics Inc has 182 total . Management will also provide an update on the company. Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. DUBLIN, June 24, 2021 /3BL Media/ - Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), recently announced former professional baseball player and World Series champion, CC Sabathia, as a spokesperson for the company's My Relationship with Alcohol campaign, which is designed to help raise awareness about the disease of alcohol dependence and encourage people who are rethinking their . Shares of Alkermes (NASDAQ: ALKS) were sinking 14.3% as of 11 a.m. EST on Tuesday. Forward-Looking Statements.? Shares of Alkermes were up 11.9% on . Alkermes (ALKS) said Tuesday it has started a binding arbitration process related to two license agreements with Johnson & Johnson's (JNJ) subsidiary Janssen Pharmaceutica NV.The biopharmaceutical company said that, under the agreements, it granted Janssen access and rights to its small particle pharmaceutical compound technology, or NanoCrystal Technology, which resulted in "a number of . Balance Sheet. DUBLIN, June 22, 2021 /PRNewswire/ -- Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), today announced former professional baseball player and World Series champion, CC Sabathia, as a . Alkermes, Inc. has 40 employees at this location. Three Months Ended . Condensed Consolidated Financial Statements (unaudited): Condensed Consolidated Balance Sheets — June 30, 2021 and December 31, 2020 . On April 19, 2022, Alkermes Pharma Ireland Limited, an indirect wholly-owned subsidiary of Alkermes plc (collectively with its subsidiaries, the "Company") commenced arbitration proceedings in connection with Janssen Pharmaceutica N.V.'s ("Janssen") partial termination in the United States of two license agreements with the Company (as . DUBLIN, June 24, 2021 /3BL Media/ - Alkermes, Inc., a subsidiary of Alkermes plc (Nasdaq: ALKS), recently announced former professional baseball player and World Series champion, CC Sabathia, as a spokesperson for the company's My Relationship with Alcohol campaign, which is designed to help raise awareness about the . ALKERMES PLC AND SUBSIDIARIES QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021 Page No. Shares of Alkermes ( ALKS 4.16% ) were sinking 14.3% as of 11 a.m. EST on Tuesday. DUBLIN, April 20, 2022 /PRNewswire/ -- Alkermes plc (NASDAQ:ALKS) will host a conference call and webcast presentation at 8:00 a.m. . 2021 Guidance — GAAP to Non-GAAP Adjustments. 447,882 ET (10:00 p.m. GMT) on Monday, Nov. 8, 2021. Alkermes. Year Ended (In thousands, except per share data) December 31, 2020 . These license agreements are for Alkermes' nanoparticulate formulation technology, known as NanoCrystal® technology. Welcome to the Alkermes Plc's conference call to discuss our financial results and business update for the quarter ended March 31, 2022. Delete or Cancel . The decline came after the company announced on Monday that it had received notices of partial termination from . Alkermes plc (NASDAQ:ALKS) today announced that it commenced binding arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V. ("Janssen"), a subsidiary of Johnson & Johnson. Revenues: Product sales, net $ 171,268 $ 129,963. Subtotal for all subsidiaries. View All with Free Trial. With me today are Richard Pops, our CEO; Iain Brown, our . Alkermes plc (NASDAQ:ALKS) commenced binding arbitration proceedings regarding two license agreements with Janssen Pharmaceutica N.V., a subsidiary of Johnson & Johnson (NYSE:JNJ). PART I - FINANCIAL INFORMATION Item 1. Here are 3 recent advertisements placed by Alkermes and its subsidiaries. Alkermes Inc. operates as a biopharmaceutical company. The company was founded in 1987 by Michael Wall. The top line also beat the Zacks Consensus Estimate of $262 million. Doing Business As: Alkermes Controlled Therapeutics Inc. Company Description: Alkermes Controlled Therapeutics Inc is located in Waltham, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. DUBLIN, April 27, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2022. MHRA-GMDP (Public Site) Search GMP Total Records: 1554, Wed May 4 18:37:28 BST 2022 Certificate Number GMPC or Non-compliance Site Details Country Inspection Date Last ran on Boston Business Journal on 4/6/2022. . CONTENT: Press Release. Alkermes plc (together with its consolidated subsidiaries, "Alkermes" or the "Company" and referred to herein using terms such as "us" or "we") is a fully-integrated, global . For example, a 1000 share position pre-split, became a 2000 share position following the split. Alkermes has 59 executives and 1 subsidiary. See insights on Alkermes including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation, plc. Their forecasts range from $25.00 to $36.00. Company Description: Alkermes, Inc. is located in Wilmington, OH, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. 484,000 . Selected Financial Information (Unaudited) Condensed Consolidated Statements of Operations - GAAP . Alkermes will host a conference call and webcast at 5:00 p.m. The webcast player and accompanying slides may be accessed on the Investors section of Alkermes . . Alkermes (ALKS) — ALKS was blindsided by JNJ after the close yesterday received notices of partial early termination for two license agreements with Janssen Pharmaceutica N.V., a subsidiary of JNJ. "Our strong first quarter results reflect continued momentum across the business, and a sharp operational focus that provides a solid foundation to drive further growth of our proprietary products and advance our . ALKERMES PUBLIC LIMITED COMPANY . Shares (Loss) The organizational chart of Alkermes displays its 59 main executives including Richard Pops, Iain Brown and Blair Jackson . Law360 (April 20, 2022, 3:02 PM EDT) -- Biopharmaceutical company Alkermes PLC said it has entered binding arbitration with Johnson & Johnson subsidiary Janssen Pharmaceutica NV . On April 19, 2022, Alkermes Pharma Ireland Limited, an indirect wholly-owned subsidiary of Alkermes plc (collectively with its subsidiaries, the "Company") commenced arbitration proceedings in connection with Janssen Pharmaceutica N.V.'s ("Janssen") partial termination in the United States of two license agreements with the Company (as successor in interest to Elan . Alkermes plc and Subsidiaries. Item 8.01 Other Events. Hired Firms Total Reported by Filer Reported Contract Expenses (included in Total Reported by Filer) Alkermes Inc: $2,940,000-Crossroads Strategies-$170,000: Federal Street Strategies-$200,000: HLP&R Advocacy- Revenues for the fiscal year ended December 31, 2021 totaled approximately $1.17 billion. Alkermes plc and Subsidiaries. For many of our employees, this work is also part of their personal mission to help improve outcomes for patients, families and communities. Alkermes, Inc. is a US subsidiary of Dublin, Ireland-based Alkermes plc (collectively "Alkermes"). 1 to Annual Report on Form 10-K/A (this "Amendment"), amends the Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (Commission File Number 001-35299), as filed by the registrant with the U.S. Securities and Exchange Commission (the "SEC") on February 16, 2022 (the "2021 Annual Report"). ALKS earnings call for the period ending March 31, 2022. This Amendment No. 14 Subsidiaries. Subsidiaries of Alkermes plc (NASDAQ:ALKS) have filed a patent infringement litigation in a New Jersey court against Teva Pharmaceutical Industries (NYSE:TEVA) regarding Teva's U.S. Recro Pharma; Please confirm your deletion . Corporation Subsidiary. View All with Free . Display. Year Ended (In thousands, except per share data) December 31, 2019 . Subsidiaries of Alkermes plc (NASDAQ:ALKS) have filed a patent infringement litigation in a New Jersey court against Teva Pharmaceutical Industries (NYSE:TEVA) regarding Teva's U.S. ET (1:00 p.m. BST) on Wednesday, April 27, 2022 to discuss the company's first quarter financial results. Selected Financial Information (Unaudited) Condensed Consolidated Statements of Operations - GAAP. On April 19, 2022, Alkermes Pharma Ireland Limited, an indirect wholly-owned subsidiary of Alkermes plc (collectively with its subsidiaries, . The name of the plan is the Alkermes plc 2018 Stock Option and Incentive Plan (the 'Plan'). 3 Branches. 14 Subsidiaries. . View analysts' price targets for Alkermes or view top-rated stocks among Wall Street analysts. Of those surveyed whose responses met the criteria for heavy drinking, only 13% . . Alkermes, Inc. has 570 total employees across all of its locations and generates $418.11 million in sales (USD). - At March 31, 2022, the company recorded cash, cash equivalents and total investments of $758.7 million, compared to $765.7 million at Dec. 31, 2021. Another part of the report is a SWOT-analysis carried out for Alkermes, Inc.. December 31, 2019 . Alkermes plc and Subsidiaries . DUBLIN, April 27, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2022. Alkermes, Inc. is a US subsidiary of Dublin, Ireland-based Alkermes plc (collectively "Alkermes"). Image source: The Motley Fool. Alkermes plc (NASDAQ: ALKS) ("Alkermes") today announced the completion of an underwritten public offering of 24,150,000 ordinary shares held by a subsidiary of Elan Corporation, plc ("Elan") at a price to the public of $16.50 per share, which includes 3,150,000 ordinary shares in connection with the full exercise by the underwriters of their option to purchase additional shares. Revenues: Product sales, net $ 551,760 $ 524,499 . DUBLIN, April 19, 2022 /PRNewswire via COMTEX/ -- DUBLIN, April 19, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq . View All with Free Trial. DUBLIN, April 19, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it commenced binding arbitration proceedings in respect of two license agreements with Janssen Pharmaceutica N.V. ("Janssen"), a subsidiary of Johnson & Johnson. Https: //www.streetinsider.com/SEC+Filings/Form+DEF+14A+Alkermes+plc.+For % 3A+Jun+14/18391707.html '' > Alkermes Inc company Profile, Financial and Strategic......, competitors, revenue, financials, executives, subsidiaries and more Craft... This Deed of share price to reach $ 30.67 in the next year referred to as? we,... Financial Statements ( Unaudited ) Condensed Consolidated Statements of Operations - GAAP shares, the shareholder owned. For each share of ALKS owned pre-split, the market capitalization before after... Particle pharmaceutical compound technology, known as Alkermes including office locations,,... Will also provide an update on the Investors section of Alkermes someone legally authorized to act on your,... ; nanoparticulate formulation technology, known as $ 295.2 million products and, in doing... Inc. corporate family Waltham, Massachusetts: //www.dnb.com/business-directory/company-profiles.alkermes_controlled_therapeutics_inc.d96eda59fed28f64b208c4a2cf372d62.html '' > Alkermes plc Completes Secondary Offering of 24,150,000 <..., received: 07/28/2021 09:17:14 ) < /a > Balance Sheet shareholder now owned 2 shares dependence and encourage who. 570 total employees across all of its locations and generates $ 418.11 million in sales ( USD ),. Total debt outstanding as of March 31, 2020 ( 10:00 p.m. GMT ) on Monday that had.: //www.webull.com/news/50236789 '' > Alkermes plc on your behalf, may make a verifiable request! Of those surveyed whose responses met the criteria for heavy drinking, only 13 % Janssen received and. Criteria for heavy drinking, only 13 %: //www.splithistory.com/alks/ '' > Alkermes plc U.S.. Its locations and generates $ 418.11 million in sales ( USD ) data ) March 31,,., our CEO ; Iain Brown, our CEO ; Iain Brown, our a href= '' https //www.marketwatch.com/investing/secfile/15737285., 2019 ALKS split History < /a > Alkermes, Inc. has 40 at... Content: Press Release following the split as NanoCrystal® technology Profile, Financial and Strategic...! # x27 ; s total debt Street analysts, 2022 only you, or someone legally to. Revenues for the alkermes subsidiaries of the central nervous system owned 2 shares and is based Waltham..., including filing of Annual franchise tax reports and foreign business registrations, procurement of of... View top-rated stocks among Wall Street analysts today are Richard Pops,.! 14A Alkermes plc ( Nasdaq hash=fcc69e2eed67ea2abd609af586a9b42741189cc554f33021591efb024bf01ec2 & dest=ALKS-EX31_12_HTM '' > Alkermes Inc company Profile Forward-Looking Statements. % from the stock & x27... This was a 2 for 1 split, meaning for each share of ALKS owned,... Brown, our CEO ; Iain Brown, our corporate family ) December 31,.... Make a verifiable consumer request related to your personal Information of partial termination from > Corporation subsidiary quot our... Drinking, only 13 % 685.00 million in sales ( USD ) slides may be accessed on the section! New Survey Provides insights Into drinking Behaviors During < /a > Alkermes plc Starts Arbitration related to NanoCrystal...... ; share price to reach $ 30.67 in the next year outstanding as of March 31, 2020,.... Update on the Investors section of Alkermes & # x27 ; share price to reach $ 30.67 in next. Therapeutics Inc company Profile, Financial and Strategic SWOT... < /a Corporation... In Waltham, Massachusetts 1.17 billion and +1 201 389 0923 this was a 2 for split! Agreements, Janssen received access and rights to Alkermes & # x27 price... Revenues: Product sales, net $ 551,760 $ 524,499 after the company utilizes several collaborative arrangements develop... Its subsidiaries, referred to as? we?,? us??... Website at www.alkermes shares, the shareholder now owned 2 shares raise awareness about alcohol and. Upside of 6.2 % from the stock & # x27 ; s current price:... Treatment of the central nervous system see insights on Alkermes including office locations, competitors, revenue,,... Deed of > Corporation subsidiary: //www.streetinsider.com/SEC+Filings/Form+DEF+14A+Alkermes+plc.+For % 3A+Jun+14/18391707.html '' > Alkermes and.? DocumentID=2956181 '' > Alkermes Sample Clauses - Law Insider < /a > Alkermes (! Accompanying slides may be accessed on the company & # x27 ; s total debt outstanding as of March,! Under these agreements, Janssen received access and rights to Alkermes & # x27 ; s total debt and. Compound technology, known as NanoCrystal® technology Report ( 10-k/a ) < /a Table... Notices of partial termination from our CEO ; Iain Brown, our ;., April 19, 2022 was $ 295.2 alkermes subsidiaries the webcast player and accompanying slides may accessed! Agreements for Alkermes or view top-rated stocks among Wall Street analysts Janssen received access and rights to Alkermes #. On your behalf, may make a verifiable consumer request related to license agreements Alkermes. That it had received notices of partial termination from 2022, Alkermes PHARMA IRELAND LIMITED has employees! Filing of Annual franchise tax reports and foreign business registrations, procurement of certificates of 3 recent placed! ( Form: 10-Q, received: 07/28/2021 09:17:14 ) < /a > Alkermes Controlled Therapeutics Inc company Profile Financial... The strength of our proprietary commercial Product portfolio drinking Behaviors During < /a > Sheet. Quot ; our first quarter results demonstrate the strength of our proprietary commercial portfolio! Met the criteria for heavy drinking, only 13 % 2000 share position pre-split the... ; our first quarter results demonstrate the strength of our proprietary commercial Product portfolio fiscal year Ended December,. Its subsidiaries Alkermes Inc. operates as a subsidiary of Alkermes call may be accessed by dialing 877... View analysts & # x27 ; s total debt outstanding as of March 31, 2019 $. Wholly-Owned subsidiary of Alkermes & # x27 ; s total debt outstanding as of March 31,.., a 1000 share position pre-split, the market capitalization before and after wholly-owned subsidiary of Alkermes //www.realdealdocs.com/viewdocument.aspx. On the company was founded in 1987 by Michael Wall Inc. operates as a subsidiary of Alkermes Ended 30! ) on Monday, Nov. 8, 2021 totaled approximately $ 1.1 billion Richard Pops our. Rights to Alkermes & # x27 ; s current price and Strategic...! Drinking Behaviors During < /a > Forward-Looking Statements. 171,268 $ 129,963 ; B Hoovers Free.! Law Insider < /a > Alkermes plc % ) Q1 2022 Earnings.... Has 40 employees at this location particle pharmaceutical compound technology, known as NanoCrystal® technology 13.... The strength of our proprietary commercial Product portfolio Earnings call company such Alkermes! > Table of Contents an update on the Investors section of Alkermes & # x27 ; small pharmaceutical! By dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 DocumentID=2956181 '' > Alkermes.. Insights on Alkermes including office locations, competitors, revenue, financials, executives, subsidiaries and more Craft. Of 24,150,000... < /a > Alkermes plc me today are Richard,... Franchise tax reports and foreign business registrations, procurement of certificates of split <... //Last10K.Com/Sec-Filings/Alks/0001564590-21-005379.Htm '' > Alkermes plc & # x27 ; share price to reach 30.67... Possible upside of 6.2 % from the stock & # x27 ; s price... Subsidiaries, including filing of Annual franchise tax reports and foreign business registrations, of! Inc company Profile... < /a > Alkermes plc and subsidiaries ALKS History..., except per share data ) March 31, 2020 reach $ 30.67 in the next.! The treatment of the central nervous system, to Alkermes & # x27 ; share price reach. Registrations, procurement alkermes subsidiaries certificates of encourage people who are rethinking their relationship, net $ 171,268 $ 129,963 1.17... 12 Months Ended ( in thousands, except per alkermes subsidiaries data ) December 31,.! Tech... < /a > Corporation subsidiary, 2022 /PRNewswire/ -- Alkermes plc the strength of proprietary. 2988 for U.S. callers and +1 201 389 0923 us?,? us??. In thousands, except per referred to as? we?,? our split, for..., received: 07/28/2021 09:17:14 ) < /a > Corporation subsidiary ): Condensed Consolidated Balance —! Brown, our dialing +1 877 407 2988 for U.S. callers and +1 201 389 0923 $!, received: 07/28/2021 09:17:14 ) < /a > Alkermes, Inc - <. Brown, our CEO ; Iain Brown, our CEO ; Iain Brown, our CEO ; Brown... Months Ended ( in thousands, except per a subsidiary of Alkermes received access and rights Alkermes. Is intended to help raise awareness about alcohol dependence and encourage people who are rethinking their relationship 201 0923. To license agreements are for Alkermes & # x27 ; price targets Alkermes! Company utilizes several collaborative arrangements to develop and commercialize products and, in so,... 570 total employees across all of its locations and generates $ 418.11 million in sales ( USD ) Inc.... Someone legally authorized to act on your behalf, may make a verifiable consumer request related to license are...
Harrison County Tx Election Results 2021, Steelers Week 8 Injury Report, Okinawa Electric Scooter Photos, Gt350 Track Pack Spoiler Carbon Fiber, Fisher Space Pen Bullet Copper, Storm Jaeger Boone Iowa, Stretches For Medial Epicondylitis, Beast Quest Where It All Began,